Confo Therapeutics
PrivateLast Round
Series B
Jul 26, 2024
Total Funding Raised
$115.45M
Momentum Score
50 /100
Company Overview
Confo Therapeutics is a biotechnology company focused on drug discovery for single-domain antibodies, utilizing proprietary technology to develop specialized camelid antibodies that stabilize G-protein coupled receptors (GPCRs) for innovative therapeutic solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Confo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Confo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 26, 2024 | ||||
| Grant | Mar 28, 2024 | ||||
| Grant | Jun 28, 2022 | ||||
| Grant | Mar 30, 2021 | ||||
| Grant | Jun 20, 2019 | ||||
Series A | May 7, 2019 |
Key People
Founding team and executive leadership
Confo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Series B |
| Perceptive Advisors | Series A, Series B |
| Fund+ | Series A, Series B |
| Capricorn Health-tech Fund | Series A, Seed, Series B |
| V-Bio Ventures | Series A, Seed, Series B |
| VLAIO | Grant |
| Driehaus Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 39% MoM, reaching 7.9K.
Confo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Confo Therapeutics's valuation, stock price, and market status.
